Companies
- Companies
- Browse
Companies
Bioaccelerate is a drug development company that finds, develops and commercialises novel pharmaceutical products. More
Global Healthcare Investment Research, Strategic Advisory and Asset Management More
Quintiles Transnational can be your strategic partner for drug development and commercialization. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 22 pages - $500
Sep 2010 - 27 pages - $2,000
May 2011 - 15 pages - $250
Mar 2011 - 28 pages - $500
Nov 2009 - 23 pages - $1,000
Dec 2010 - 16 pages - $99
Nov 2010 - 178 pages - $1,495
Sep 2009 - 394 pages - $4,000
Jun 2009 - $15,200
Jun 2010 - 210 pages - $2,500
Your selection
Browse By
- Therapeutic target
- Adult respiratory distress syndrome
- Allergy, respiratory
- Asthma
- Asthma, bronchospasm
- Bronchitis
- Chest disorder (other)
- Chlamydia pneumoniae
- Chronic obstructive pulmonary disease
- Cough
- Cystic fibrosis
- Dysplasia, bronchopulmonary
- Emphysema
- Granulomatous lung disease sarcoidosis
- Idiopathic respiratory distress syndrome
- Meconium aspiration syndrome
- Nasal disorder (other)
- Obstructive airway disease
- Pneumonia
- Pneumonocystis carinii lung infection
- Pseudomonas lung infection
- Respiratory disorder (other)
- Respiratory syncytial virus
- Respiratory tract infections
- Rhinitis
- Rhinovirus (common cold)
- Sinusitis
- Sleep apnea
- Throat disorder (other)
- Tuberculosis
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us